PMC:7784786 / 100-244 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"33","span":{"begin":131,"end":141},"obj":"Chemical"},{"id":"36","span":{"begin":27,"end":35},"obj":"Disease"}],"attributes":[{"id":"A33","pred":"tao:has_database_id","subj":"33","obj":"MESH:C000597346"},{"id":"A36","pred":"tao:has_database_id","subj":"36","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"f three cases\n\nAbstract\nIn COVID-19, the inflammatory cytokine-release syndrome is associated with the progression of the disease. Itolizumab is"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T2","span":{"begin":54,"end":79},"obj":"Phenotype"}],"attributes":[{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0033041"}],"text":"f three cases\n\nAbstract\nIn COVID-19, the inflammatory cytokine-release syndrome is associated with the progression of the disease. Itolizumab is"}

{"project":"LitCovid-sentences","denotations":[{"id":"T2","span":{"begin":15,"end":23},"obj":"Sentence"},{"id":"T3","span":{"begin":24,"end":130},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"f three cases\n\nAbstract\nIn COVID-19, the inflammatory cytokine-release syndrome is associated with the progression of the disease. Itolizumab is"}